Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Penile cancer - Incidence, mortality, and survival in Saxony, Germany.

Schoffer O, Neumann A, Stabenow R, Schülein S, Böhm WD, Gonsior A, Horn LC, Kriegel C, Stolzenburg JU, Wirth M, Klug SJ.

Urol Oncol. 2019 Apr;37(4):295.e1-295.e8. doi: 10.1016/j.urolonc.2018.12.003. Epub 2018 Dec 27.

PMID:
30595462
2.

The need to collect, aggregate, and analyze global anesthesia and surgery data.

Juran S, Gruendl M, Marks IH, Broer PN, Guzman JM, Davies J, Shrime M, Johnson W, Holmer H, Peck G, Makasa E, Hagander L, Klug SJ, Meara JG, Gelb AW, Ljungman D.

Can J Anaesth. 2019 Feb;66(2):218-229. doi: 10.1007/s12630-018-1261-5. Epub 2018 Nov 27.

PMID:
30484168
3.

[Cervical cancer screening in Germany].

Bujan Rivera J, Klug SJ.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Dec;61(12):1528-1535. doi: 10.1007/s00103-018-2835-7. Review. German.

PMID:
30397722
4.

[The STIKO now recommends the HPV vaccination for boys too].

Klug SJ, van der Sande M, Terhardt M, Zepp F, Röbl-Mathieu M, Meerpohl J, Wiese-Posselt M, Harder T, Wichmann O, Takla A; Ständige Impfkommission (STIKO) und AG HPV der STIKO.

Urologe A. 2018 Nov;57(11):1346-1350. doi: 10.1007/s00120-018-0793-1. German. No abstract available.

PMID:
30324393
5.

A Web-based survey among adults aged 40-54 years was time effective and yielded stable response patterns.

Weigl K, Tikk K, Hoffmeister M, De Toni EN, Hampe J, Kolligs F, Klug SJ, Mansmann U, Nasseh D, Radlovic J, Schwab M, Schweigler D, Stephan AM, Brenner H.

J Clin Epidemiol. 2019 Jan;105:10-18. doi: 10.1016/j.jclinepi.2018.08.021. Epub 2018 Sep 6.

PMID:
30196128
6.

Evaluation of the methodological quality of articles on autologous breast reconstruction.

Schülein S, Taylor KJ, Braun B, Heyl V, Zoche H, Peek A, Solbach C, Schott S, Blettner M, Klug SJ.

J Plast Reconstr Aesthet Surg. 2018 Sep;71(9):1286-1294. doi: 10.1016/j.bjps.2018.05.010. Epub 2018 Jun 8. Review.

PMID:
30173715
7.

Background paper for the recommendation of HPV vaccination for boys in Germany.

Takla A, Wiese-Posselt M, Harder T, Meerpohl JJ, Röbl-Mathieu M, Terhardt M, van der Sande M, Wichmann O, Zepp F, Klug SJ.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Sep;61(9):1170-1186. doi: 10.1007/s00103-018-2791-2. Review. No abstract available.

PMID:
30167729
8.

Geospatial mapping of access to timely essential surgery in sub-Saharan Africa.

Juran S, Broer PN, Klug SJ, Snow RC, Okiro EA, Ouma PO, Snow RW, Tatem AJ, Meara JG, Alegana VA.

BMJ Glob Health. 2018 Aug 16;3(4):e000875. doi: 10.1136/bmjgh-2018-000875. eCollection 2018.

9.

Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.

Harder T, Wichmann O, Klug SJ, van der Sande MAB, Wiese-Posselt M.

BMC Med. 2018 Jul 18;16(1):110. doi: 10.1186/s12916-018-1098-3. Review.

10.

Study protocol of the RaPS study: novel risk adapted prevention strategies for people with a family history of colorectal cancer.

Tikk K, Weigl K, Hoffmeister M, Igel S, Schwab M, Hampe J, Klug SJ, Mansmann U, Kolligs F, Brenner H.

BMC Cancer. 2018 Jul 6;18(1):720. doi: 10.1186/s12885-018-4646-5.

11.

Cancer incidence in Germany attributable to human papillomavirus in 2013.

Buttmann-Schweiger N, Deleré Y, Klug SJ, Kraywinkel K.

BMC Cancer. 2017 Oct 16;17(1):682. doi: 10.1186/s12885-017-3678-6.

12.

Trastuzumab and survival of patients with metastatic breast cancer.

Kast K, Schoffer O, Link T, Forberger A, Petzold A, Niedostatek A, Werner C, Klug SJ, Werner A, Gatzweiler A, Richter B, Baretton G, Wimberger P.

Arch Gynecol Obstet. 2017 Aug;296(2):303-312. doi: 10.1007/s00404-017-4421-x. Epub 2017 Jun 14.

PMID:
28616827
13.

Colonoscopy in Germany-Important Steps Towards a National Screening Program.

Klug SJ.

Dtsch Arztebl Int. 2017 Feb 10;114(6):85-86. doi: 10.3238/arztebl.2017.0085. No abstract available.

14.

Participation in preventive health check-ups among 19,351 women in Germany.

Schülein S, Taylor KJ, Schriefer D, Blettner M, Klug SJ.

Prev Med Rep. 2017 Jan 26;6:23-26. doi: 10.1016/j.pmedr.2017.01.011. eCollection 2017 Jun.

15.

Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.

Schoffer O, Schülein S, Arand G, Arnholdt H, Baaske D, Bargou RC, Becker N, Beckmann MW, Bodack Y, Böhme B, Bozkurt T, Breitsprecher R, Buchali A, Burger E, Burger U, Dommisch K, Elsner G, Fernschild K, Flintzer U, Funke U, Gerken M, Göbel H, Grobe N, Gumpp V, Heinzerling L, Kempfer LR, Kiani A, Klinkhammer-Schalke M, Klöcking S, Kreibich U, Knabner K, Kuhn P, Lutze S, Mäder U, Maisel T, Maschke J, Middeke M, Neubauer A, Niedostatek A, Opazo-Saez A, Peters C, Schell B, Schenkirsch G, Schmalenberg H, Schmidt P, Schneider C, Schubotz B, Seide A, Strecker P, Taubenheim S, Wackes M, Weiß S, Welke C, Werner C, Wittekind C, Wulff J, Zettl H, Klug SJ.

BMC Cancer. 2016 Dec 5;16(1):936.

16.

The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program.

Neumann A, Lindholm L, Norberg M, Schoffer O, Klug SJ, Norström F.

Eur J Health Econ. 2017 Sep;18(7):905-919. doi: 10.1007/s10198-016-0851-9. Epub 2016 Dec 2.

17.

Factors influencing uptake of HPV vaccination among girls in Germany.

Schülein S, Taylor KJ, König J, Claus M, Blettner M, Klug SJ.

BMC Public Health. 2016 Sep 20;16:995. doi: 10.1186/s12889-016-3663-z.

18.

Invitation to cervical cancer screening does increase participation in Germany: Results from the MARZY study.

Radde K, Gottschalk A, Bussas U, Schülein S, Schriefer D, Seifert U, Neumann A, Kaiser M, Blettner M, Klug SJ.

Int J Cancer. 2016 Sep 1;139(5):1018-30. doi: 10.1002/ijc.30146. Epub 2016 May 13.

19.

Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients.

Dornbusch J, Walter M, Gottschalk A, Obaje A, Junker K, Ohlmann CH, Meinhardt M, Zacharis A, Zastrow S, Schoffer O, Grimm MO, Klug SJ, Wirth MP, Fuessel S.

J Cancer Res Clin Oncol. 2016 Jun;142(6):1171-82. doi: 10.1007/s00432-016-2137-0. Epub 2016 Mar 3.

PMID:
26935927
20.

[Screening for cancer].

Seifert U, Schlanstedt-Jahn U, Klug SJ.

Internist (Berl). 2015 Oct;56(10):1114-23. doi: 10.1007/s00108-015-3738-4. German.

PMID:
26384500
21.

Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis.

Buttmann-Schweiger N, Klug SJ, Luyten A, Holleczek B, Heitz F, du Bois A, Kraywinkel K.

PLoS One. 2015 May 28;10(5):e0128073. doi: 10.1371/journal.pone.0128073. eCollection 2015.

22.

Impact of breast cancer subtypes and patterns of metastasis on outcome.

Kast K, Link T, Friedrich K, Petzold A, Niedostatek A, Schoffer O, Werner C, Klug SJ, Werner A, Gatzweiler A, Richter B, Baretton G, Wimberger P.

Breast Cancer Res Treat. 2015 Apr;150(3):621-9. doi: 10.1007/s10549-015-3341-3. Epub 2015 Mar 18.

PMID:
25783184
23.

[Quality assurance in an epidemiological cohort study: on-site monitoring in gynaecological practices].

Zeissig SR, Radde K, Kaiser M, Blettner M, Klug SJ.

Z Evid Fortbild Qual Gesundhwes. 2014;108(8-9):517-27. doi: 10.1016/j.zefq.2014.08.001. Epub 2014 Nov 5. German.

PMID:
25523851
24.

Health-related quality of life for pre-diabetic states and type 2 diabetes mellitus: a cross-sectional study in Västerbotten Sweden.

Neumann A, Schoffer O, Norström F, Norberg M, Klug SJ, Lindholm L.

Health Qual Life Outcomes. 2014 Oct 24;12:150. doi: 10.1186/s12955-014-0150-z.

25.

The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.

Deleré Y, Wichmann O, Klug SJ, van der Sande M, Terhardt M, Zepp F, Harder T.

Dtsch Arztebl Int. 2014 Sep 1;111(35-36):584-91. doi: 10.3238/arztebl.2014.0584. Review.

26.

[Early detection of cervical cancer in Germany: evidence and implementation].

Seifert U, Klug SJ.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Mar;57(3):294-301. doi: 10.1007/s00103-013-1903-2. German.

PMID:
24562703
27.

Risk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program.

Neumann A, Norberg M, Schoffer O, Norström F, Johansson I, Klug SJ, Lindholm L.

BMC Public Health. 2013 Oct 26;13:1014. doi: 10.1186/1471-2458-13-1014.

28.

Influence of GSM signals on human peripheral lymphocytes: study of genotoxicity.

Waldmann P, Bohnenberger S, Greinert R, Hermann-Then B, Heselich A, Klug SJ, Koenig J, Kuhr K, Kuster N, Merker M, Murbach M, Pollet D, Schadenboeck W, Scheidemann-Wesp U, Schwab B, Volkmer B, Weyer V, Blettner M.

Radiat Res. 2013 Feb;179(2):243-53. doi: 10.1667/RR2914.1. Epub 2013 Jan 14.

PMID:
23316708
29.

A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance.

Klug SJ, Neis KJ, Harlfinger W, Malter A, König J, Spieth S, Brinkmann-Smetanay F, Kommoss F, Weyer V, Ikenberg H.

Int J Cancer. 2013 Jun 15;132(12):2849-57. doi: 10.1002/ijc.27955. Epub 2012 Dec 14.

30.

HPV infection awareness and self-reported HPV vaccination coverage in female adolescent students in two German cities.

Samkange-Zeeb F, Spallek L, Klug SJ, Zeeb H.

J Community Health. 2012 Dec;37(6):1151-6. doi: 10.1007/s10900-012-9589-1.

PMID:
22772842
31.

Colonoscopy screening in Germany--a success story?

Klug SJ.

Dtsch Arztebl Int. 2010 Oct;107(43):751-2. doi: 10.3238/arztebl.2010.0751. Epub 2010 Oct 29. No abstract available.

32.

Participation in cervical cancer screening in Germany.

Klug SJ, Taylor KJ, Scheidemann-Wesp U, Lautz D, Güther B, Potthoff P, Blettner M.

Prev Med. 2010 Nov;51(5):431-2. doi: 10.1016/j.ypmed.2010.08.008. Epub 2010 Aug 22. No abstract available.

PMID:
20736032
33.

Data analysis of epidemiological studies: part 11 of a series on evaluation of scientific publications.

Ressing M, Blettner M, Klug SJ.

Dtsch Arztebl Int. 2010 Mar;107(11):187-92. doi: 10.3238/arztebl.2010.0187. Epub 2010 Mar 19.

34.

Systematic literature reviews and meta-analyses: part 6 of a series on evaluation of scientific publications.

Ressing M, Blettner M, Klug SJ.

Dtsch Arztebl Int. 2009 Jul;106(27):456-63. doi: 10.3238/arztebl.2009.0456. Epub 2009 Jul 3. Review.

35.

TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.

Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das BR, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y, Pegoraro R, Pillai MR, Ranzani G, Rezza G, Rosenthal AN, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-Ishida W, Shirasawa H, Snijders PJ, Stoler MH, Suárez-Rincón AE, Szarka K, Tachezy R, Ueda M, van der Zee AG, von Knebel Doeberitz M, Wu MT, Yamashita T, Zehbe I, Blettner M.

Lancet Oncol. 2009 Aug;10(8):772-84. doi: 10.1016/S1470-2045(09)70187-1. Epub 2009 Jul 20.

PMID:
19625214
36.

Early detection of cervical carcinomas: finding an overall approach.

Wentzensen N, Klug SJ.

Dtsch Arztebl Int. 2008 Sep;105(37):617-22. doi: 10.3238/arztebl.2008.0617. Epub 2008 Sep 12.

37.

Cervical cancer control in the era of HPV vaccination and novel biomarkers.

Wentzensen N, Klug SJ.

Pathobiology. 2009;76(2):82-9. doi: 10.1159/000201676. Epub 2009 Apr 9. Review.

38.

[Comparison of ICD coding between mortality statistics and study-intern retrospective re-coding].

Klug SJ, Bardehle D, Ressing M, Schmidtmann I, Blettner M.

Gesundheitswesen. 2009 Apr;71(4):220-5. doi: 10.1055/s-0028-1102929. Epub 2009 Feb 16. German.

PMID:
19221984
39.

Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.

Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W, J F Snijders P, Petry KU, Krüger Kjaer S, Munk C, Iftner T.

J Med Virol. 2008 Jul;80(7):1264-74. doi: 10.1002/jmv.21191.

PMID:
18461626
40.

Knowledge about infection with human papillomavirus: a systematic review.

Klug SJ, Hukelmann M, Blettner M.

Prev Med. 2008 Feb;46(2):87-98. Epub 2007 Sep 14. Review.

PMID:
17942147
41.

[Common study designs in epidemiology].

Klug SJ, Bender R, Blettner M, Lange S.

Dtsch Med Wochenschr. 2007;132 Suppl 1:e45-7. German. No abstract available.

PMID:
17530597
42.

[Planning, implementation and evaluation of cancer screening programs].

Giersiepen K, Hense HW, Klug SJ, Antes G, Zeeb H.

Z Arztl Fortbild Qualitatssich. 2007;101(1):43-9. German.

PMID:
17458364
43.

Prevalence of human papillomavirus types in women screened by cytology in Germany.

Klug SJ, Hukelmann M, Hollwitz B, Düzenli N, Schopp B, Petry KU, Iftner T.

J Med Virol. 2007 May;79(5):616-25.

PMID:
17385693
44.
45.

Mortality among workers employed in the titanium dioxide production industry in Europe.

Boffetta P, Soutar A, Cherrie JW, Granath F, Andersen A, Anttila A, Blettner M, Gaborieau V, Klug SJ, Langard S, Luce D, Merletti F, Miller B, Mirabelli D, Pukkala E, Adami HO, Weiderpass E.

Cancer Causes Control. 2004 Sep;15(7):697-706.

PMID:
15280628
46.
47.
48.

TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors.

Pütz A, Hartmann AA, Fontes PR, Alexandre CO, Silveira DA, Klug SJ, Rabes HM.

Int J Cancer. 2002 Mar 1;98(1):99-105.

49.

TP53 polymorphism, HPV infection, and risk of cervical cancer.

Klug SJ, Wilmotte R, Santos C, Almonte M, Herrero R, Guerrero I, Caceres E, Peixoto-Guimaraes D, Lenoir G, Hainaut P, Walboomers JM, Muñoz N.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):1009-12.

50.

Human papillomavirus infection and invasive cervical cancer in Paraguay.

Rolón PA, Smith JS, Muñoz N, Klug SJ, Herrero R, Bosch X, Llamosas F, Meijer CJ, Walboomers JM.

Int J Cancer. 2000 Feb 15;85(4):486-91.

Supplemental Content

Support Center